| ID | Name | CAS | Properties |
MW (g/mol) |
| 49-975-6 |
5«alpha»-Pregnan-3«beta»,20«alpha»-diol, allyl-DMS
|
|
2 | 502.92 |
| 50-024-9 |
Acetic acid, (3,4-dihydro-5-nitro-4-oxo-6-pyrimidinyl)hydrazide
|
30958-43-1 |
2 | 213.15 |
| 50-038-4 |
Triazolo [4,5-d]pyrimidine, 3h-v-, 5,7-diamino-3-ethyl-
|
7256-20-4 |
2 | 179.18 |
| 50-110-3 |
Urea, 1-(2-hydroxyethyl)-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-
|
|
2 | 214.18 |
| 50-209-4 |
N-(3-Bromo-4-hydroxy-phenyl)-4-nitro-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 517.54 |
| 50-214-8 |
Silane, (9,19-cyclo-9«beta»-lanost-24-en-3«beta»-yloxy)trimethyl-
|
17608-55-8 |
2 | 498.90 |
| 50-286-9 |
3-(4-Hydroxyphenyl)propionic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 394.70 |
| 50-346-2 |
Oxadiazole, 1,2,4-, 5-(5-nitrofuran-2-yl)-3-(4-pyridinyl)-
|
|
2 | 258.19 |
| 50-387-7 |
Benzeneacetic acid, «alpha»,3,4-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
37148-65-5 |
2 | 472.87 |
| 50-415-5 |
17-«alpha»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 462.86 |
| 50-503-7 |
Anthracene, 1,2,3,4-tetrahydro-trans-1,2-diol, DTBS
|
|
2 | 354.56 |
| 50-517-2 |
5«beta»-Homocholane-3«alpha»,7«alpha»,12«alpha»,25-tetrol, TMS
|
|
2 | 697.34 |
| 50-521-7 |
3«beta»,4«beta»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
2 | 727.32 |
| 50-529-9 |
Cholan-24-oic acid, 3,7,12-tris[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,7«alpha»,12«alpha»)-
|
6818-43-5 |
2 | 639.14 |
| 50-582-0 |
7«alpha»-hydroxy-3-oxo-4-chol-24-oate, O-methyloxime, TMS (1)
|
|
2 | 561.94 |
| 50-591-0 |
7-«alpha»,17-«beta»-Dimethyl-5-«beta»-Androstane-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 464.87 |
| 50-626-1 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)heptyloxy-
|
|
2 | 352.63 |
| 50-735-0 |
9H-purine-9-acetic acid, 6(1h)-thio-, ethyl ester
|
|
2 | 238.27 |
| 50-804-3 |
13,14-Dihydro-15-keto-PGE2, MO-TMS, isomer # 1
|
|
2 | 554.92 |
| 50-836-8 |
3«alpha»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS, (syn,anti)
|
|
2 | 538.00 |
| 50-844-9 |
Indeno[1,2-c]pyrazol-4-one, 7-chloro-3-propyl-, hydrazone
|
116434-72-1 |
2 | 260.72 |
| 50-892-6 |
[1,2,5]Thiadiazolo[3,4-d]pyrimidine, 7-(hydroxyamino)-
|
|
2 | 169.16 |
| 50-956-5 |
N6-(cyclotetramethylene-tertbutylsilyl)-Adenosine, 2',3',5'-tris-O-TBDMS
|
|
2 | 750.32 |
| 50-997-0 |
3-«alpha»,6-«alpha»,12-«alpha»-Trihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 639.14 |
| 51-026-6 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,17-O)-diTMTBSi, (20-O)-TMSi
|
|
2 | 689.29 |
| 51-081-5 |
4-Imidazole carboxamide,5-(3-methyl-3-pentyl-1-triazeno)-
|
18910-61-7 |
2 | 238.29 |
| 51-093-2 |
(E/Z)-3«beta»-Acetoxytrimethylsilyloxylup-20(29)-ene, # 1
|
|
2 | 556.93 |
| 51-193-1 |
Oxime of 5-acetyl-4-methyl-4-thiazoline-2-thione
|
|
2 | 188.28 |
| 51-228-2 |
7«alpha»-hydroxy-3-oxo-4-cholesten-26-oate, oxime-TMS
|
|
2 | 660.21 |
| 51-368-7 |
16«alpha», 17-H2-17-OH GA20 methyl ester TMS ether
|
|
2 | 508.80 |
| 51-446-0 |
3«beta»,7«alpha»-Dihydroxy-4-cholenic acid, methyl ester, TMS
|
|
2 | 548.94 |
| 51-494-7 |
9-Dodecyn-1-ol, dimethyl(dimethyl(pyrid-2-ylmethoxy)silyloxy)silyl ether
|
|
2 | 421.73 |
| 51-500-9 |
2,3,10,11-Tetrahydrobenzo[b]dipyrido[3,2,1-de:1,2,3-mn]-phenazine-1,12-dione
|
|
2 | 340.38 |
| 51-595-5 |
Ribonic acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
57197-35-0 |
2 | 527.03 |
| 51-618-9 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 51-817-8 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate, TMS
|
|
2 | 432.52 |
| 52-107-5 |
9,10-Anthracenedione, 3-methyl-1,6,8-tris[(trimethylsilyl)oxy]-
|
7336-74-5 |
2 | 486.78 |
| 52-316-3 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, per-TMS
|
|
2 | 448.83 |
| 52-337-0 |
D-Mannitol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
14317-07-8 |
2 | 615.26 |
| 52-371-2 |
(3R,4S)-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonyl-3-hydroxyazepane
|
|
2 | 345.55 |
| 52-375-8 |
5.beta.-pregn-7-ene-3.alpha.,17.alpha.,20.alpha.-triol
|
|
2 | 551.05 |
| 52-464-9 |
D-Gluconic acid, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
34290-52-3 |
2 | 629.24 |
| 52-470-2 |
L-Cystine, N,N1-bis(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 697.36 |
| 52-523-3 |
Propanoic acid, 2-methyl-2,3-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
38166-00-6 |
2 | 336.65 |
| 52-568-4 |
4-(2-tert-Butyldimethylsilylamino-1-t-butyldimethylsilyloxyethyl)phenol, tert-butyldimethylsilyl ether
|
|
2 | 495.97 |
| 52-626-9 |
Urea, 1-methyl-1-nitroso-3-[(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)methyl-
|
|
2 | 227.18 |
| 52-740-2 |
4-(7-Ethyl-3-methyl-5-propenyl-2,3-dihydro-benzofuran-2-yl)-2,6-dimethoxy-phenol, TES
|
|
2 | 468.70 |
| 52-770-9 |
tert-Butyl-[2-[2-[2-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 598.97 |
| 52-777-2 |
6.alpha.,17.beta.-Dihydroxy-5.alpha.-androstan-3-one, TMS
|
|
2 | 522.99 |
| 52-783-5 |
3-HYDROXY-3-(4'-HYDROXY-3'-METHOXYPHENYL)PROPIONIC ACID TRITMS
|
|
2 | 428.75 |
| 52-792-5 |
Selenoethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 352.33 |
| 52-797-0 |
1,5,7-Trimethyl-2-nitro-imidazo[4,5,d]pyrimidin-4,6-dione
|
|
2 | 239.19 |
| 52-801-4 |
5-Cholesten-3-.beta.,27-diol-17,22-dione, TMS
|
|
2 | 719.36 |
| 52-880-7 |
5«beta»-Androstan-7«alpha»,17«alpha»-dimethyl-3«alpha»,17«beta»-diol, TMS
|
|
2 | 464.87 |
| 52-884-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, methylboronate
|
|
2 | 250.10 |
| 52-917-6 |
L-Serine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107715-93-5 |
2 | 447.88 |
| 53-065-1 |
Silane, diphenylpentyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 461.39 |
| 53-082-2 |
(E)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 507.57 |
| 53-090-3 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 53-122-7 |
Benzaldehyde, 2-hydroxy, 3-nitro-5-tert.-octyl, oxime, TMS
|
|
2 | 382.60 |
| 53-127-2 |
2-Deoxy-D-ribose, tris(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 437.88 |
| 53-163-2 |
4-ISOPROPYL-2,6,7-TRIOXA-1-PHOSPHABICYCLO[2.2.2]OCTANE 1-OXIDE
|
|
2 | 192.15 |
| 53-178-6 |
Naphtho[2,3-d]-1,2,3-triazin-4(3H)-one, 3-phenyl-
|
|
2 | 273.29 |
| 53-406-2 |
5«alpha»-Pregnan-3«beta»,20«beta»-diol, allyl-DMS
|
|
2 | 502.92 |
| 53-458-5 |
3«alpha»,5«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 651.20 |
| 53-489-1 |
Glycine, N-(2-methyl-1-oxo-2-propenyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55557-27-2 |
2 | 287.50 |
| 53-502-5 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTBDMS
|
|
2 | 532.99 |
| 53-635-8 |
(3R,4S)-3-Azido-4-tert-butyldimethylsilyloxy-1-tert-butoxycarbonylazepane
|
|
2 | 370.56 |
| 53-644-8 |
2-Amino-3,5,7,8-tetrahydro-4,6-pteridinedione
|
1011-23-0 |
2 | 181.15 |
| 53-712-2 |
4-(tert-Butylamino)-6-ethyl-6-trimethylsilylamino-5H-1,3,5-triazin-2-one
|
|
2 | 283.45 |
| 53-737-5 |
5«beta»-Androst-1-ene-3«alpha»,17«alpha»-diol, per-TMS
|
|
2 | 434.80 |
| 53-771-7 |
N-tert-Butyl-N'-tert-butyldimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
2 | 311.50 |
| 53-789-8 |
Androst-1,4-dien-17«beta»-ol-3-one, TMS
|
|
2 | 430.77 |
| 53-895-0 |
Nickel complex of 2,2'-thiobis[4-(1,1,3,3-tetramethylbutyl)phenol]
|
|
2 | 501.39 |
| 53-903-0 |
4-Pregnen-20-«alpha»-ol-3,11-dione, MO-TMS
|
|
2 | 460.72 |
| 53-929-2 |
5-«beta»-Pregnan-3-«alpha»-ol-11,20-dione, MO-TMS
|
|
2 | 462.74 |
| 54-056-0 |
2,2,4,6,8-pentamethyl-4,6,8-tri(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 413.73 |
| 54-070-4 |
Thiazolo[5,4-d]pyrimidine, 5-amino-2-[(2-chloroethyl)thio]-7-(ethylamino)-
|
|
2 | 289.82 |
| 54-118-1 |
2,2,4,4,6-pentamethyl-6-(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 261.50 |
| 54-340-4 |
2,6-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 496.90 |
| 54-432-2 |
5«beta»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
|
2 | 539.03 |
| 54-472-8 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 54-567-3 |
3«alpha»,15«alpha»-dihydroxy-5«beta»-androstan-17-one, TMS
|
|
2 | 522.98 |
| 54-619-5 |
3-«beta»,7-«alpha»,12-«alpha»-Trihydroxy-4-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 54-675-3 |
Benzoic acid, 2-(3-butyl-3-methyl-1-triazeno)-, hydrazide
|
116466-08-1 |
2 | 249.31 |
| 54-724-8 |
5«beta»-Pregnane-3«beta»,17«alpha»-diol-20-one, MO TMS
|
|
2 | 507.90 |
| 54-882-3 |
Trimethylsilyl (2Z)-4-methyl-2-[(trimethylsilyl)oxy]pent-2-enoate
|
|
2 | 274.50 |
| 54-925-5 |
Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-butyl, oxime, TMS
|
|
2 | 372.05 |
| 54-939-0 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMIPS
|
|
2 | 557.01 |
| 55-150-4 |
N6-(cyclotetramethylene-tertbutylsilyl)-2'-Deoxyadenosine, 3',5'-bis-O-TBDMS
|
|
2 | 620.06 |
| 55-182-9 |
3-Acetyl-5-methylmercapto-1,3,4-thiadiazolidone-2-azine
|
109967-13-7 |
2 | 376.50 |
| 55-306-1 |
3-(Pyrrol[3-(1-ethylbutoxy)-1,1,3,3-tetramethyldisiloxanyl]oxymorphomethyl)pyridine
|
|
2 | 341.60 |
| 55-339-5 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M ((dihydro-), TMS
|
|
2 | 321.49 |
| 55-354-8 |
Caffeic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
180715-88-2 |
2 | 522.94 |
| 55-413-2 |
7«beta»,16«alpha»,17-triOH-kauranoic acid, methyl ester TMS ether
|
|
2 | 583.03 |
| 55-435-8 |
16«beta», 17-H2-17-OH GA20 methyl ester TMS ether
|
|
2 | 508.80 |
| 55-472-7 |
Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-
|
13909-02-9 |
2 | 262.65 |
| 55-613-0 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
2 | 635.11 |
| 55-638-3 |
3A,17A,21-Trihydroxy-5B-pregnan-20-one, MO TMS
|
|
2 | 596.09 |
| 55-651-8 |
N6-TFA-2'-Deoxyadenosine, 3'-O-TFA, 5'-O-TBDMS
|
|
2 | 557.52 |
|
« Previous Results
Next Results »
|